Market Access -

Trending

in News
US buys Lilly COVID antibody, as effectiveness questions remain
October 28, 2020 Share
X
US buys Lilly COVID antibody, as effectiveness questions remain
https://pharmaphorum.com/news/us-buys-300000-doses-lilly-covid-antibody/
in News
FDA sets April verdict for Pfizer’s “underestimated” atopic dermatitis drug
October 28, 2020 Share
X
FDA sets April verdict for Pfizer’s “underestimated” atopic dermatitis drug
https://pharmaphorum.com/news/fda-sets-april-verdict-for-pfizers-underestimated-atopic-dermatitis-drug/

Latest News

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot

Russia’s sovereign wealth fund has filed applications with the World Health Organization (WHO) that if approved could see

X

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot

https://pharmaphorum.com/market-access-2/russias-sputnik-v-covid-19-shot-filed-with-who/

AZ, J&J COVID-19 vaccine trials okay to restart in US

AZ, J&J COVID-19 vaccine trials okay to restart in US

US trials of AstraZeneca’s experimental COVID-19 vaccine AZD1222 have been cleared to restart by the FDA, several weeks

X

AZ, J&J COVID-19 vaccine trials okay to restart in US

https://pharmaphorum.com/news/az-jj-coronavirus-vaccine-trials-okay-to-restart-in-us/

Gilead’s remdesivir finally gets US approval

Gilead’s remdesivir finally gets US approval

Gilead’s Veklury (remdesivir) has become the first COVID-19 drug approved in the US following a nod from the

X

Gilead’s remdesivir finally gets US approval

https://pharmaphorum.com/news/gileads-remdesivir-finally-gets-us-approval/

Views & analysis

NICE talking to you: Trends in early HTA engagement

NICE talking to you: Trends in early HTA engagement

With exclusive data from Freedom of Information (FOI) requests sent to the National Institute for Health and are

X

NICE talking to you: Trends in early HTA engagement

https://pharmaphorum.com/views-analysis-market-access/nice-talking-to-you/

Pharma’s response to COVID: GSK

Pharma’s response to COVID: GSK

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus

X

Pharma’s response to COVID: GSK

https://pharmaphorum.com/views-analysis-sales-marketing/pharmas-response-to-covid-gsk/

Why intelligent automation is the future for regulatory

Why intelligent automation is the future for regulatory

There are a host of new, previously unimaginable tools and techniques – from analytics to robotic process automation

X

Why intelligent automation is the future for regulatory

https://pharmaphorum.com/views-analysis-digital/why-intelligent-automation-is-the-future-for-regulatory/

Debates & Insights

Innovative contracting in Europe – a Trojan horse?

Innovative contracting in Europe – a Trojan horse?

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing

X

Innovative contracting in Europe – a Trojan horse?

https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/

Launch excellence in a disrupted world – challenges & opportunities

Launch excellence in a disrupted world – challenges & opportunities

Overview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care

X

Launch excellence in a disrupted world – challenges & opportunities

https://pharmaphorum.com/market-access-2/launch-excellence-in-a-disrupted-world-challenges-opportunities/

Orphan medicines launch excellence: sustaining launch success

Orphan medicines launch excellence: sustaining launch success

Overview Launching orphan medicines excellently will become even more important over the next five years as more patients

X

Orphan medicines launch excellence: sustaining launch success

https://pharmaphorum.com/market-access-2/orphan-medicines-launch-excellence-sustaining-launch-success/

Partner Content

Registration opens for Pre-filled Syringes & Injectable Devices Conference 2021

Registration opens for Pre-filled Syringes & Injectable Devices Conference 2021

Registration opens for Pre-filled Syringes Conference

X

Registration opens for Pre-filled Syringes & Injectable Devices Conference 2021

https://pharmaphorum.com/partner-content/registration-opens-for-pre-filled-syringes-injectable-devices-conference-2021/

Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020

Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020

Exclusive interview with ForwardVue Pharma

X

Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020

https://pharmaphorum.com/partner-content/exclusive-interview-with-forwardvue-pharma-released-for-ophthalmic-drugs-2020/

Pre-filled Syringes San Francisco will now take place as a Virtual Conference

Pre-filled Syringes San Francisco will now take place as a Virtual Conference

Pre-filled Syringes San Francisco is now Virtual

X

Pre-filled Syringes San Francisco will now take place as a Virtual Conference

https://pharmaphorum.com/partner-content/pre-filled-syringes-san-francisco-will-now-take-place-as-a-virtual-conference/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com